November 2025
The global gene therapy market size was exhibited at USD 11.07 billion in 2025 and is predicted to hit around USD 55.43 billion by 2034 with a solid CAGR of 19.60%.
November 2025
The global AAV gene therapy market size was evaluated at USD 2,853.36 million in 2025 and is predicted to hit around USD 23,546.27 million by 2034, with a CAGR of 26.43%.
October 2025
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
October 2025
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
August 2025
The global cell and gene therapy market size was calculated at USD 7.79 billion in 2024 and is projected to surpass around USD 39.61billion by 2034 with a solid CAGR of 17.98%.
August 2025
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 6.31 billion in 2024, with a CAGR of 27.92%.
July 2025
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
July 2025
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 548.55 million in 2024, with a CAGR of 7.34%.
July 2025
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 11.60 billion in 2024, with a CAGR of 26.62%.
July 2025
The cell and gene therapy infrastructure market is expanding with scalable manufacturing, integrated delivery networks, and advanced clinical site readiness.
July 2025
Explore the cell and gene therapy patient access and reimbursement Market, driven by evolving payer policies, value-based care models, and rising adoption of high-cost cell and gene therapies.
July 2025
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
January 2025
The global cancer gene therapy market size was estimated at USD 3.44 billion in 2024 and is projected to hit around USD 19.97 billion by 2034, poised to grow at a CAGR of 19.23% during the forecast period from 2025 to 2034.
February 2026
The global neurointerventional devices market size was valued at USD 3.41 billion in 2025 and is expected to attain around USD 6.91 billion by 2035 with a CAGR of 7.32%.
February 2026
The global urodynamic equipment and consumables market size is expected to worth around USD 845.42 million by 2035 from USD 477.99 million in 2025, at a CAGR of 5.87%.
February 2026
The global light therapy market size reached USD 1.16 billion in 2025 and is projected to hit around USD 1.72 billion by 2035, growing at a CAGR of 4.02%.
February 2026
The global surgical gloves market size accounted for USD 3.47 billion in 2025 and is predicted to increase from USD 3.92 billion in 2026 to approximately USD 9.30 billion by 2035, expanding at a CAGR of 10.36% from 2026 to 2035.
February 2026
The global generative AI in pharmaceutical market is surging, with an overall revenue growth expectation of hundreds of millions of dollars during the forecast period from 2026 to 2035.
February 2026
The global veterinary medicine market size was valued at USD 56.68 billion in 2025 and is expected to worth around USD 115.15 billion by 2035 with a CAGR of 7.35%.
February 2026
The global immunoassay market size was calculated at USD 37.23 billion in 2025 and is projected to surpass around USD 58.64 billion by 2035, growing at a CAGR of 4.65%.
February 2026
The global ophthalmic drugs market size accounted for USD 45.35 billion in 2025 and is expected to exceed USD 75.79 billion by 2035, growing at a CAGR of 5.27% from 2026 to 2035.
February 2026
The U.S. medical billing outsourcing market size is estimated at USD 6.64 billion in 2025 and is predicted to be worth around USD 20.39 billion by 2035, growing at a notable CAGR of 11.87% from 2026 to 2035.
February 2026
The global assisted reproductive technology market size accounted for USD 34.71 billion in 2025 and is anticipated to reach around USD 87.27 billion by 2035, growing at a CAGR of 9.66% from 2026 to 2035.
February 2026
The global home infusion therapy market size was estimated at USD 41.83 billion in 2025 and is anticipated to reach around USD 90.65 billion by 2035, expanding at a CAGR of 8.04% from 2026 to 2035.
February 2026
The global dental imaging market size was valued at USD 5.24 billion in 2025 and is expected to hit USD 12.53 billion by 2035, with a CAGR of 9.11%.
February 2026
The global herpes treatment market size was evaluated at USD 1.51 billion in 2025 and is predicted to hit around USD 3.92 billion by 2035, growing at a CAGR of 10.00%.
February 2026
The global gastrointestinal bleeding treatment market size was evaluated at USD 316.02 million in 2025 and is predicted to hit around USD 889.26 million by 2035, growing at a CAGR of 10.90%.
February 2026
The global blood-based non-invasive screening market size was evaluated at USD 15.00 billion in 2025 and is predicted to hit around USD 48.71 billion by 2035, growing at a CAGR of 12.50%.
February 2026
The global carbamazepine market size was evaluated at USD 1.46 billion in 2025 and is predicted to hit around USD 2.85 billion by 2035, growing at a CAGR of 6.90%.